https://www.selleckchem.com/pr....oducts/2-2-2-tribrom
61, 95% CI 1.12-2.17; p = 0.00. Significant differences were noted between groups in terms of thrombosis/embolism, neutropenia, and febrile neutropenia. CONCLUSIONS In Chinese women with ACC, cisplatin-based chemotherapy plus BEV is associated with improved survival compared to cisplatin-based chemotherapy alone. This finding suggests a positive survival benefit of anti-angiogenesis therapy in this population.BACKGROUND Declines in bone, muscle and physical performance are associated with adverse health outcomes in older
Like
Comment
Share
